Where does Loci Orthopaedics Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Loci Orthopaedics Limited ranks #48,433 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Loci Orthopaedics Limited hold?

Loci Orthopaedics Limited holds 5 US utility patents granted between 2020 and 2024, spanning 2 technology areas.

What is Loci Orthopaedics Limited's Innovation Score?

Loci Orthopaedics Limited has an Innovation Score of 44.0 out of 100 (top 27% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Loci Orthopaedics Limited's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Loci Orthopaedics Limited.

What does claim depth mean for Loci Orthopaedics Limited's patents?

Loci Orthopaedics Limited's patents average 21.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Loci Orthopaedics Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Loci Orthopaedics Limited

Q: What technology areas does Loci Orthopaedics Limited focus on?

Loci Orthopaedics Limited's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 5 patents. Grants appear in 2 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Loci ranks #48,433 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.

#48,433
of 49,997 US assignees by volume: Top 27%
by Innovation Score (44.0/100): 21.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R48433 · Foreign Corporation #48,433 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #48,433/49,997
PHOTO-FINISH Liverpool School of…
CPC-NARROW A61F · 2 areas
INNOV-PAR 44.0/100
CLAIMS-DENSE 21.4 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2024 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Liverpool School of Tropical Medicine (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Institute of New… · near

44
Carlisle Constructio… · near

44
Directa Plus S p A · near

44
Loci Orthopaedics · this assignee

44
Lumentum Japan · near

44
3D Lighting… · lowest

7

What this shows Loci's Innovation Score is 44.0/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Loci's grants concentrate

Loci Orthopaedics Limited is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2020. By volume, Loci sits between Liverpool School of Tropical Medicine and Los Angeles Biomedical Research Institute.

Loci's three-year grant acceleration

Loci Orthopaedics Limited shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Liverpool School…

5
Livescribe

5
Living technology…

5
Local Bounti Oper…

5
Loftie

5
Logicblox

5
Lombardini S r L

5
Los Angeles Biome…

5
Loci Orthopaedics ◀

5

What this shows Loci holds 5 patents at rank #48,478, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Loci

By rank, the assignees closest to #48,478 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Loci's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Loci, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Directa Plus S.p.A. 44 Carlisle Construction Materials, LLC 44 Lumentum Japan, Inc. 44 Institute of New Materials, Guangdong Academy of Sciences 44

Loci's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Loci Orthopaedics Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	20.0%
2023	2	40.0%
2024	2	40.0%

Which technologies does Loci Orthopaedics Limited patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 5

A61B - DIAGNOSIS; SURGERY; Identification 2

Top 2 of 2 technology areas

Where it ranks

Overall rank by patents

#48,433

of 49,997 tracked assignees

Innovation Score

44.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Loci Orthopaedics Limited's patent record in context - here's where to go next.

Loci Orthopaedics Limited's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #48,433 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Loci Orthopaedics Limited against Liverpool School of Tropical Medicine, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.